Published in Cell Stem Cell on May 28, 2009
Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell (2010) 14.18
Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature (2009) 8.70
Variation in the safety of induced pluripotent stem cell lines. Nat Biotechnol (2009) 6.39
Regeneration and orthotopic transplantation of a bioartificial lung. Nat Med (2010) 5.59
Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci (2009) 5.58
The promise of induced pluripotent stem cells in research and therapy. Nature (2012) 5.05
Induced pluripotency: history, mechanisms, and applications. Genes Dev (2010) 4.89
A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog. Cell Stem Cell (2009) 4.64
A nonviral minicircle vector for deriving human iPS cells. Nat Methods (2010) 4.42
Direct reprogramming of human neural stem cells by OCT4. Nature (2009) 4.32
Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood (2009) 4.22
Direct reprogramming of mouse fibroblasts to neural progenitors. Proc Natl Acad Sci U S A (2011) 3.93
Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures. Cell Res (2011) 3.58
Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes. Stem Cells (2010) 3.53
Technical challenges in using human induced pluripotent stem cells to model disease. Cell Stem Cell (2009) 3.42
Progress toward the clinical application of patient-specific pluripotent stem cells. J Clin Invest (2010) 3.12
Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. Cell Stem Cell (2009) 3.12
Activation of innate immunity is required for efficient nuclear reprogramming. Cell (2012) 2.99
Reprogramming of T cells from human peripheral blood. Cell Stem Cell (2010) 2.93
Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells. PLoS One (2010) 2.86
Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc Natl Acad Sci U S A (2010) 2.85
Harnessing the potential of induced pluripotent stem cells for regenerative medicine. Nat Cell Biol (2011) 2.74
Induced pluripotent stem cells--opportunities for disease modelling and drug discovery. Nat Rev Drug Discov (2011) 2.58
In situ genetic correction of the sickle cell anemia mutation in human induced pluripotent stem cells using engineered zinc finger nucleases. Stem Cells (2011) 2.52
Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors. Proc Natl Acad Sci U S A (2011) 2.51
Induced pluripotent stem cells: the new patient? Nat Rev Mol Cell Biol (2012) 2.50
Promotion of direct reprogramming by transformation-deficient Myc. Proc Natl Acad Sci U S A (2010) 2.44
A vector-free microfluidic platform for intracellular delivery. Proc Natl Acad Sci U S A (2013) 2.40
Generation of human-induced pluripotent stem cells in the absence of exogenous Sox2. Stem Cells (2009) 2.29
Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson disease. J Clin Invest (2011) 2.23
Induced pluripotent stem cells: opportunities and challenges. Philos Trans R Soc Lond B Biol Sci (2011) 2.09
Human ES- and iPS-derived myogenic progenitors restore DYSTROPHIN and improve contractility upon transplantation in dystrophic mice. Cell Stem Cell (2012) 2.06
Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules. Cell Res (2010) 2.04
RUNX1a enhances hematopoietic lineage commitment from human embryonic stem cells and inducible pluripotent stem cells. Blood (2013) 2.00
Engineering of human pluripotent stem cells by AAV-mediated gene targeting. Mol Ther (2010) 1.99
Endothelial cells derived from human iPSCS increase capillary density and improve perfusion in a mouse model of peripheral arterial disease. Arterioscler Thromb Vasc Biol (2011) 1.93
Small molecule Wnt inhibitors enhance the efficiency of BMP-4-directed cardiac differentiation of human pluripotent stem cells. J Mol Cell Cardiol (2011) 1.93
Generation of mouse-induced pluripotent stem cells with plasmid vectors. Nat Protoc (2010) 1.93
Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells. Blood (2011) 1.92
iPS cells reprogrammed from human mesenchymal-like stem/progenitor cells of dental tissue origin. Stem Cells Dev (2010) 1.73
Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells. Blood (2009) 1.73
Spinal muscular atrophy: mechanisms and therapeutic strategies. Hum Mol Genet (2010) 1.73
Induced pluripotent stem cells: developmental biology to regenerative medicine. Nat Rev Cardiol (2010) 1.71
Present state and future perspectives of using pluripotent stem cells in toxicology research. Arch Toxicol (2011) 1.69
Realistic control of network dynamics. Nat Commun (2013) 1.63
Cardiac cell repair therapy: a clinical perspective. Mayo Clin Proc (2009) 1.62
Stem cells in retinal regeneration: past, present and future. Development (2013) 1.59
Mesenchymal stem cells for bone repair and metabolic bone diseases. Mayo Clin Proc (2009) 1.59
The gold rush for induced pluripotent stem cells. Nat Biotechnol (2009) 1.55
Generation of keratinocytes from normal and recessive dystrophic epidermolysis bullosa-induced pluripotent stem cells. Proc Natl Acad Sci U S A (2011) 1.54
Induction of pluripotent stem cells from human third molar mesenchymal stromal cells. J Biol Chem (2010) 1.50
The promise of human embryonic stem cells in aging-associated diseases. Aging (Albany NY) (2011) 1.49
Developing safe therapies from human pluripotent stem cells. Nat Biotechnol (2009) 1.48
Platelets generated from human embryonic stem cells are functional in vitro and in the microcirculation of living mice. Cell Res (2011) 1.48
Sequential introduction of reprogramming factors reveals a time-sensitive requirement for individual factors and a sequential EMT-MET mechanism for optimal reprogramming. Nat Cell Biol (2013) 1.47
Enhanced generation of induced pluripotent stem cells from a subpopulation of human fibroblasts. PLoS One (2009) 1.47
The quantitative proteomes of human-induced pluripotent stem cells and embryonic stem cells. Mol Syst Biol (2011) 1.44
Current status of islet cell replacement and regeneration therapy. J Clin Endocrinol Metab (2010) 1.43
Feeder-free derivation of human induced pluripotent stem cells with messenger RNA. Sci Rep (2012) 1.42
Biomedical Application of Dental Tissue-Derived Induced Pluripotent Stem Cells. Stem Cells Int (2016) 1.42
Reprogramming to pluripotency: stepwise resetting of the epigenetic landscape. Cell Res (2011) 1.41
Generation of human induced pluripotent stem cells from umbilical cord matrix and amniotic membrane mesenchymal cells. J Biol Chem (2010) 1.41
Genetic and epigenetic stability of human pluripotent stem cells. Nat Rev Genet (2012) 1.38
Reprogramming of mouse and human somatic cells by high-performance engineered factors. EMBO Rep (2011) 1.38
Reprogramming human fibroblasts to pluripotency using modified mRNA. Nat Protoc (2013) 1.36
Stem cell therapies for spinal cord injury. Nat Rev Neurol (2010) 1.35
Reprogramming of EBV-immortalized B-lymphocyte cell lines into induced pluripotent stem cells. Blood (2011) 1.34
Generation of human induced pluripotent stem cells by simple transient transfection of plasmid DNA encoding reprogramming factors. BMC Dev Biol (2010) 1.33
Generation of integration-free human induced pluripotent stem cells from postnatal blood mononuclear cells by plasmid vector expression. Nat Protoc (2012) 1.32
Human pluripotent stem cells: applications and challenges in neurological diseases. Front Physiol (2012) 1.31
Generation of induced pluripotent stem cells from newborn marmoset skin fibroblasts. Stem Cell Res (2010) 1.31
Human iPS cell-based therapy: considerations before clinical applications. Cell Cycle (2010) 1.29
Human stem cells and drug screening: opportunities and challenges. Nat Rev Drug Discov (2010) 1.24
Molecular signatures of human induced pluripotent stem cells highlight sex differences and cancer genes. Cell Stem Cell (2012) 1.23
Generating a non-integrating human induced pluripotent stem cell bank from urine-derived cells. PLoS One (2013) 1.22
A review of the methods for human iPSC derivation. Methods Mol Biol (2013) 1.22
Global transcriptional profiles of beating clusters derived from human induced pluripotent stem cells and embryonic stem cells are highly similar. BMC Dev Biol (2010) 1.21
Pre-evaluated safe human iPSC-derived neural stem cells promote functional recovery after spinal cord injury in common marmoset without tumorigenicity. PLoS One (2012) 1.20
Fifteen years of cell-penetrating, guanidinium-rich molecular transporters: basic science, research tools, and clinical applications. Acc Chem Res (2013) 1.20
Cell transplantation therapies for spinal cord injury focusing on induced pluripotent stem cells. Cell Res (2012) 1.19
Genetic correction of β-thalassemia patient-specific iPS cells and its use in improving hemoglobin production in irradiated SCID mice. Cell Res (2012) 1.18
Current status of pluripotent stem cells: moving the first therapies to the clinic. Nat Rev Drug Discov (2015) 1.18
A protocol describing the genetic correction of somatic human cells and subsequent generation of iPS cells. Nat Protoc (2010) 1.17
EOS lentiviral vector selection system for human induced pluripotent stem cells. Nat Protoc (2009) 1.17
Derivation of human induced pluripotent stem cells for cardiovascular disease modeling. Circ Res (2011) 1.17
Induced pluripotent stem cell lines derived from equine fibroblasts. Stem Cell Rev (2011) 1.17
A decade of transcription factor-mediated reprogramming to pluripotency. Nat Rev Mol Cell Biol (2016) 1.16
Stem cell technology for the study and treatment of motor neuron diseases. Regen Med (2011) 1.16
Developmental and regenerative biology of multipotent cardiovascular progenitor cells. Circ Res (2011) 1.16
Protein delivery into live cells by incubation with an endosomolytic agent. Nat Methods (2014) 1.16
Functional modules distinguish human induced pluripotent stem cells from embryonic stem cells. Stem Cells Dev (2011) 1.15
Generation and characterization of transgene-free human induced pluripotent stem cells and conversion to putative clinical-grade status. Stem Cell Res Ther (2013) 1.14
The challenge of immunogenicity in the quest for induced pluripotency. Nat Rev Immunol (2010) 1.14
Induced pluripotent stem cells: at the heart of cardiovascular precision medicine. Nat Rev Cardiol (2016) 1.13
Lithium, an anti-psychotic drug, greatly enhances the generation of induced pluripotent stem cells. Cell Res (2011) 1.13
Innate immune suppression enables frequent transfection with RNA encoding reprogramming proteins. PLoS One (2010) 1.13
Technological overview of iPS induction from human adult somatic cells. Curr Gene Ther (2013) 1.13
Small molecules, big roles -- the chemical manipulation of stem cell fate and somatic cell reprogramming. J Cell Sci (2012) 1.12
Generation of retinal pigment epithelial cells from small molecules and OCT4 reprogrammed human induced pluripotent stem cells. Stem Cells Transl Med (2012) 1.11
Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approach. Mol Ther (2012) 1.10
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Induced pluripotent stem cell lines derived from human somatic cells. Science (2007) 71.50
Generation of germline-competent induced pluripotent stem cells. Nature (2007) 32.77
Reprogramming of human somatic cells to pluripotency with defined factors. Nature (2007) 30.84
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature (2007) 28.24
Viable offspring derived from fetal and adult mammalian cells. Nature (1997) 22.46
Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell (2007) 21.58
Human induced pluripotent stem cells free of vector and transgene sequences. Science (2009) 17.16
Generation of mouse induced pluripotent stem cells without viral vectors. Science (2008) 15.25
Induced pluripotent stem cells generated without viral integration. Science (2008) 13.38
Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell (2009) 13.02
Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science (2007) 12.41
Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell (2009) 11.65
piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature (2009) 11.27
Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol (2008) 10.29
Cellular uptake of the tat protein from human immunodeficiency virus. Cell (1988) 10.19
Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature (2009) 9.29
Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell (2008) 7.79
Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci U S A (2008) 7.52
Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell (2007) 6.62
The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc Natl Acad Sci U S A (2000) 5.81
A fresh look at iPS cells. Cell (2009) 5.73
Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors. Cell Stem Cell (2008) 4.63
Tat protein from human immunodeficiency virus forms a metal-linked dimer. Science (1988) 4.63
Delivery of macromolecules using arginine-rich cell-penetrating peptides: ways to overcome endosomal entrapment. AAPS J (2009) 1.99
The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence. Biochemistry (2005) 1.87
Development of human cloned blastocysts following somatic cell nuclear transfer with adult fibroblasts. Stem Cells (2008) 1.57
Reprogramming of human somatic cells using human and animal oocytes. Cloning Stem Cells (2009) 1.40
Nuclear delivery of macromolecules: barriers and carriers. Adv Drug Deliv Rev (2004) 1.30
Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet (2012) 7.70
Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci U S A (2002) 4.20
Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells (2010) 3.48
Depletion of human micro-RNA miR-125b reveals that it is critical for the proliferation of differentiated cells but not for the down-regulation of putative targets during differentiation. J Biol Chem (2005) 3.33
Human embryonic stem cell lines derived from single blastomeres. Nature (2006) 3.12
Human embryonic stem cell lines generated without embryo destruction. Cell Stem Cell (2008) 3.11
Biologic properties and enucleation of red blood cells from human embryonic stem cells. Blood (2008) 3.01
Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration. Stem Cells (2009) 2.56
A vector-free microfluidic platform for intracellular delivery. Proc Natl Acad Sci U S A (2013) 2.40
Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics. Cloning Stem Cells (2004) 2.32
Efficient differentiation of functional hepatocytes from human embryonic stem cells. Stem Cells (2008) 2.29
Human embryonic stem cells derived without feeder cells. Lancet (2005) 2.24
Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson disease. J Clin Invest (2011) 2.23
Human embryonic stem cell-derived cells rescue visual function in dystrophic RCS rats. Cloning Stem Cells (2006) 2.23
LRRK2 regulates synaptic vesicle endocytosis. Exp Cell Res (2008) 2.09
Generation of functional hemangioblasts from human embryonic stem cells. Nat Methods (2007) 2.06
Platelet bioreactor-on-a-chip. Blood (2014) 1.87
Embryonic and extraembryonic stem cell lines derived from single mouse blastomeres. Nature (2005) 1.86
In vitro and in vivo analyses of human embryonic stem cell-derived dopamine neurons. J Neurochem (2005) 1.86
A double blind study showing that two weeks of daily repetitive TMS over the left or right temporoparietal cortex reduces symptoms in patients with schizophrenia who are having treatment-refractory auditory hallucinations. Neurosci Lett (2004) 1.79
Functional analysis of various promoters in lentiviral vectors at different stages of in vitro differentiation of mouse embryonic stem cells. Mol Ther (2007) 1.76
Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons. Eur J Neurosci (2002) 1.75
Essential role for TRPC5 in amygdala function and fear-related behavior. Cell (2009) 1.72
Analysis of different promoter systems for efficient transgene expression in mouse embryonic stem cell lines. Stem Cells (2002) 1.67
Selective loss of dopaminergic neurons in the substantia nigra of Pitx3-deficient aphakia mice. Brain Res Mol Brain Res (2003) 1.66
3,4-dihydroxyphenylalanine reverses the motor deficits in Pitx3-deficient aphakia mice: behavioral characterization of a novel genetic model of Parkinson's disease. J Neurosci (2005) 1.52
Wnt1-lmx1a forms a novel autoregulatory loop and controls midbrain dopaminergic differentiation synergistically with the SHH-FoxA2 pathway. Cell Stem Cell (2009) 1.51
MicroRNA profiling reveals two distinct p53-related human pluripotent stem cell states. Cell Stem Cell (2010) 1.49
The apolipoprotein E epsilon4 haplotype is an important predictor for recurrence in ischemic cerebrovascular disease. J Neurol Sci (2003) 1.49
Platelets generated from human embryonic stem cells are functional in vitro and in the microcirculation of living mice. Cell Res (2011) 1.48
Genetic selection of sox1GFP-expressing neural precursors removes residual tumorigenic pluripotent stem cells and attenuates tumor formation after transplantation. J Neurochem (2006) 1.46
Orphan nuclear receptor Nurr1 directly transactivates the promoter activity of the tyrosine hydroxylase gene in a cell-specific manner. J Neurochem (2003) 1.40
Reprogramming of human somatic cells using human and animal oocytes. Cloning Stem Cells (2009) 1.40
Derive and conquer: sourcing and differentiating stem cells for therapeutic applications. Nat Rev Drug Discov (2008) 1.38
Lithium selectively increases neuronal differentiation of hippocampal neural progenitor cells both in vitro and in vivo. J Neurochem (2004) 1.35
Derivation of human embryonic stem cells from single blastomeres. Nat Protoc (2007) 1.32
The homeodomain transcription factor Pitx3 facilitates differentiation of mouse embryonic stem cells into AHD2-expressing dopaminergic neurons. Mol Cell Neurosci (2005) 1.29
Mitochondrial cyclic AMP response element-binding protein (CREB) mediates mitochondrial gene expression and neuronal survival. J Biol Chem (2005) 1.25
Anxiogenic-like effect of chronic corticosterone in the light-dark emergence task in mice. Behav Neurosci (2006) 1.24
A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder. Proc Natl Acad Sci U S A (2006) 1.23
Changes to upper eyelid orbital fat from use of topical bimatoprost, travoprost, and latanoprost. Jpn J Ophthalmol (2011) 1.23
Association study of four polymorphisms in three folate-related enzyme genes with non-obstructive male infertility. Hum Reprod (2006) 1.22
Neural precursors derived from human embryonic stem cells maintain long-term proliferation without losing the potential to differentiate into all three neural lineages, including dopaminergic neurons. J Neurochem (2007) 1.22
Inhibition of pluripotent stem cell-derived teratoma formation by small molecules. Proc Natl Acad Sci U S A (2013) 1.22
Stromal cell-derived inducing activity, Nurr1, and signaling molecules synergistically induce dopaminergic neurons from mouse embryonic stem cells. Stem Cells (2005) 1.22
Live births after vitrification of oocytes in a stimulated in vitro fertilization-embryo transfer program. Fertil Steril (2003) 1.21
LRRK2 enhances oxidative stress-induced neurotoxicity via its kinase activity. Exp Cell Res (2009) 1.21
Molecular consequences of PHOX2B missense, frameshift and alanine expansion mutations leading to autonomic dysfunction. Hum Mol Genet (2005) 1.20
Primary bone-derived cells induce osteogenic differentiation without exogenous factors in human embryonic stem cells. Biochem Biophys Res Commun (2005) 1.19
Temporally induced Nurr1 can induce a non-neuronal dopaminergic cell type in embryonic stem cell differentiation. Eur J Neurosci (2004) 1.18
ES cell-derived renewable and functional midbrain dopaminergic progenitors. Proc Natl Acad Sci U S A (2011) 1.17
Survival rate of human oocytes and pregnancy outcome after vitrification using slush nitrogen in assisted reproductive technologies. Fertil Steril (2007) 1.12
PEST motif sequence regulating human NANOG for proteasomal degradation. Stem Cells Dev (2011) 1.11
Mutations in the dopamine beta-hydroxylase gene are associated with human norepinephrine deficiency. Am J Med Genet (2002) 1.11
Mesenchymal stem cell population derived from human pluripotent stem cells displays potent immunomodulatory and therapeutic properties. Stem Cells Dev (2014) 1.10
Differential gene expression in retinoic acid-induced differentiation of acute promyelocytic leukemia cells, NB4 and HL-60 cells. Biochem Biophys Res Commun (2002) 1.08
Possible association between -G308A tumour necrosis factor-alpha gene polymorphism and major depressive disorder in the Korean population. Psychiatr Genet (2003) 1.07
Neural precursors derived from embryonic stem cells, but not those from fetal ventral mesencephalon, maintain the potential to differentiate into dopaminergic neurons after expansion in vitro. Stem Cells (2006) 1.05
Expression of angiogenesis- and apoptosis-related genes in chorionic villi derived from recurrent pregnancy loss patients. Mol Reprod Dev (2003) 1.02
Direct reprogramming of rat neural precursor cells and fibroblasts into pluripotent stem cells. PLoS One (2010) 1.02
Dopaminergic neuronal differentiation from rat embryonic neural precursors by Nurr1 overexpression. J Neurochem (2003) 1.01
Mesodermal cell types induce neurogenesis from adult human hippocampal progenitor cells. J Neurochem (2006) 1.01
Differentially expressed proteins in gastrointestinal stromal tumors with KIT and PDGFRA mutations. Proteomics (2006) 1.01
Comparison of FRPE and human embryonic stem cell-derived RPE behavior on aged human Bruch's membrane. Invest Ophthalmol Vis Sci (2011) 1.01
Multipotent neural stem cells from the adult tegmentum with dopaminergic potential develop essential properties of functional neurons. Stem Cells (2005) 1.00
Chronic 3,4-dihydroxyphenylalanine treatment induces dyskinesia in aphakia mice, a novel genetic model of Parkinson's disease. Neurobiol Dis (2007) 0.99
Recombinant HoxB4 fusion proteins enhance hematopoietic differentiation of human embryonic stem cells. Stem Cells Dev (2007) 0.99
Coordinate Regulation of Neurite Outgrowth by LRRK2 and Its Interactor, Rab5. Exp Neurobiol (2010) 0.98
Regulation of the tyrosine hydroxylase gene promoter by histone deacetylase inhibitors. Biochem Biophys Res Commun (2003) 0.98
Ascorbate-induced differentiation of embryonic cortical precursors into neurons and astrocytes. J Neurosci Res (2003) 0.97
Efficient specification of interneurons from human pluripotent stem cells by dorsoventral and rostrocaudal modulation. Stem Cells (2014) 0.97
Enhanced in vitro midbrain dopamine neuron differentiation, dopaminergic function, neurite outgrowth, and 1-methyl-4-phenylpyridium resistance in mouse embryonic stem cells overexpressing Bcl-XL. J Neurosci (2004) 0.96
Expression of the LRRK2 gene in the midbrain dopaminergic neurons of the substantia nigra. Neurosci Lett (2008) 0.95
Human placenta-derived mesenchymal stem cells promote hepatic regeneration in CCl4 -injured rat liver model via increased autophagic mechanism. Stem Cells (2013) 0.95
Proteomic analysis of recurrent spontaneous abortion: Identification of an inadequately expressed set of proteins in human follicular fluid. Proteomics (2006) 0.95
Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of stomach cancer in a Korean population. Anticancer Res (2005) 0.94
Generation of functional dopamine neurons from neural precursor cells isolated from the subventricular zone and white matter of the adult rat brain using Nurr1 overexpression. Stem Cells (2007) 0.94
Hemangioblasts from human embryonic stem cells generate multilayered blood vessels with functional smooth muscle cells. Regen Med (2009) 0.93
Vesicular monoamine transporter 2 and dopamine transporter are molecular targets of Pitx3 in the ventral midbrain dopamine neurons. J Neurochem (2009) 0.93
GeneChip analysis of human embryonic stem cell differentiation into hemangioblasts: an in silico dissection of mixed phenotypes. Genome Biol (2007) 0.92
Differential gene expression profiles of metastases in paired primary and metastatic colorectal carcinomas. Oncology (2008) 0.92
Differential actions of the proneural genes encoding Mash1 and neurogenins in Nurr1-induced dopamine neuron differentiation. J Cell Sci (2006) 0.92